Gain Therapeutics Stock Price History

GANX Stock  USD 1.74  0.01  0.58%   
If you're considering investing in Gain Stock, it is important to understand the factors that can impact its price. As of today, the current price of Gain Therapeutics stands at 1.74, as last reported on the 27th of November, with the highest price reaching 1.86 and the lowest price hitting 1.71 during the day. Gain Therapeutics is very risky given 3 months investment horizon. Gain Therapeutics holds Efficiency (Sharpe) Ratio of 0.14, which attests that the entity had a 0.14% return per unit of risk over the last 3 months. We were able to interpolate twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.0% are justified by taking the suggested risk. Use Gain Therapeutics Downside Deviation of 7.2, market risk adjusted performance of 0.6069, and Risk Adjusted Performance of 0.0754 to evaluate company specific risk that cannot be diversified away.
  
At this time, Gain Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Common Stock Total Equity is likely to rise to 1,436 in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 11.9 M in 2024. . At this time, Gain Therapeutics' Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to rise to 3.55 in 2024, whereas Price To Sales Ratio is likely to drop 732.51 in 2024. Gain Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1394

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsGANX
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 7.18
  actual daily
63
63% of assets are less volatile

Expected Return

 1.0
  actual daily
19
81% of assets have higher returns

Risk-Adjusted Return

 0.14
  actual daily
10
90% of assets perform better
Based on monthly moving average Gain Therapeutics is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Gain Therapeutics by adding it to a well-diversified portfolio.
Price Book
5.1506
Enterprise Value Ebitda
(1.55)
Price Sales
925.9162
Shares Float
24.2 M
Wall Street Target Price
7.4

Gain Therapeutics Stock Price History Chart

There are several ways to analyze Gain Stock price data. The simplest method is using a basic Gain candlestick price chart, which shows Gain Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceOctober 16, 20242.92
Lowest PriceSeptember 4, 20241.04

Gain Therapeutics November 27, 2024 Stock Price Synopsis

Various analyses of Gain Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Gain Stock. It can be used to describe the percentage change in the price of Gain Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Gain Stock.
Gain Therapeutics Price Rate Of Daily Change 1.01 
Gain Therapeutics Price Action Indicator(0.04)
Gain Therapeutics Accumulation Distribution 20,846 
Gain Therapeutics Price Daily Balance Of Power 0.07 

Gain Therapeutics November 27, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Gain Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Gain Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Gain Stock and then apply it to test your longer-term investment strategies against Gain.

Gain Stock Price History Data

The price series of Gain Therapeutics for the period between Thu, Aug 29, 2024 and Wed, Nov 27, 2024 has a statistical range of 1.88 with a coefficient of variation of 26.96. Under current investment horizon, the daily prices are spread out with arithmetic mean of 1.88. The median price for the last 90 days is 1.82.
OpenHighLowCloseVolume
11/27/2024 1.73  1.86  1.71  1.74  258,491 
11/26/2024 1.83  1.85  1.72  1.73  76,783 
11/25/2024 1.79  1.90  1.76  1.82  239,450 
11/22/2024 1.60  1.78  1.56  1.72  205,127 
11/21/2024 1.65  1.75  1.56  1.62  194,626 
11/20/2024 1.68  1.75  1.61  1.66  141,791 
11/19/2024 1.69  1.77  1.63  1.72  190,383 
11/18/2024 1.87  2.00  1.63  1.69  407,466 
11/15/2024 1.66  1.90  1.66  1.85  450,962 
11/14/2024 2.03  2.03  1.64  1.75  438,485 
11/13/2024 2.10  2.19  1.94  2.03  223,740 
11/12/2024 2.14  2.19  2.02  2.08  192,367 
11/11/2024 2.20  2.25  2.05  2.17  197,859 
11/08/2024 2.23  2.28  2.10  2.22  156,005 
11/07/2024 2.29  2.34  2.19  2.23  165,108 
11/06/2024 2.24  2.31  2.20  2.27  224,176 
11/05/2024 2.06  2.30  2.02  2.22  191,973 
11/04/2024 2.29  2.39  2.07  2.07  398,533 
11/01/2024 2.53  2.55  2.30  2.32  351,319 
10/31/2024 2.15  2.56  2.15  2.50  478,781 
10/30/2024 2.55  2.58  2.12  2.18  500,180 
10/29/2024 2.63  2.67  2.27  2.57  359,437 
10/28/2024 2.68  2.75  2.60  2.65  140,503 
10/25/2024 2.66  2.74  2.57  2.65  259,072 
10/24/2024 2.75  2.75  2.60  2.68  239,689 
10/23/2024 2.80  2.80  2.55  2.68  219,514 
10/22/2024 2.80  2.81  2.53  2.69  230,134 
10/21/2024 2.71  2.82  2.63  2.79  218,233 
10/18/2024 2.80  2.90  2.45  2.70  424,766 
10/17/2024 2.99  3.19  2.70  2.77  775,978 
10/16/2024 2.42  3.14  2.35  2.92  1,199,685 
10/15/2024 2.35  2.52  2.17  2.40  683,821 
10/14/2024 2.06  2.36  2.05  2.35  583,457 
10/11/2024 1.99  2.08  1.94  2.07  195,201 
10/10/2024 2.05  2.05  1.91  1.97  177,363 
10/09/2024 2.08  2.08  1.90  2.04  235,029 
10/08/2024 2.16  2.16  1.87  1.98  295,480 
10/07/2024 1.90  2.14  1.83  2.13  598,162 
10/04/2024 1.73  1.84  1.71  1.82  304,509 
10/03/2024 1.69  1.77  1.58  1.72  286,450 
10/02/2024 1.66  1.67  1.58  1.64  144,729 
10/01/2024 1.81  1.81  1.54  1.64  399,891 
09/30/2024 1.99  1.99  1.63  1.78  609,138 
09/27/2024 1.85  2.00  1.82  1.99  621,680 
09/26/2024 1.85  1.85  1.54  1.85  404,064 
09/25/2024 1.68  1.85  1.63  1.78  599,231 
09/24/2024 1.55  1.64  1.54  1.62  241,763 
09/23/2024 1.47  1.78  1.45  1.55  310,055 
09/20/2024 1.52  1.55  1.43  1.43  384,592 
09/19/2024 1.50  1.55  1.46  1.50  174,603 
09/18/2024 1.50  1.50  1.36  1.48  237,741 
09/17/2024 1.49  1.50  1.42  1.50  201,261 
09/16/2024 1.45  1.54  1.41  1.48  167,430 
09/13/2024 1.44  1.53  1.40  1.47  123,836 
09/12/2024 1.48  1.50  1.37  1.47  143,959 
09/11/2024 1.33  1.56  1.33  1.49  647,165 
09/10/2024 1.16  1.43  1.13  1.27  418,885 
09/09/2024 1.04  1.18  1.00  1.16  294,816 
09/06/2024 1.07  1.10  1.00  1.05  237,826 
09/05/2024 1.04  1.11  1.02  1.09  105,209 
09/04/2024 1.04  1.06  1.01  1.04  142,765 

About Gain Therapeutics Stock history

Gain Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Gain is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Gain Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Gain Therapeutics stock prices may prove useful in developing a viable investing in Gain Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding13 M11.9 M
Net Loss-15.8 M-15 M

Gain Therapeutics Quarterly Net Working Capital

12.02 Million

Gain Therapeutics Stock Technical Analysis

Gain Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Gain Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Gain Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run ETF Categories Now

   

ETF Categories

List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
All  Next Launch Module

Gain Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Gain Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Gain Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Gain to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Gain Stock Analysis

When running Gain Therapeutics' price analysis, check to measure Gain Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gain Therapeutics is operating at the current time. Most of Gain Therapeutics' value examination focuses on studying past and present price action to predict the probability of Gain Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gain Therapeutics' price. Additionally, you may evaluate how the addition of Gain Therapeutics to your portfolios can decrease your overall portfolio volatility.